Sb Investment Advisers (Uk) LTD Roivant Sciences Ltd. Transaction History
Sb Investment Advisers (Uk) LTD
- $12.1 Billion
- Q3 2024
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 65,934,074 shares of ROIV stock, worth $789 Million. This represents 6.27% of its overall portfolio holdings.
Number of Shares
65,934,074
Previous 71,361,388
7.61%
Holding current value
$789 Million
Previous $754 Million
0.87%
% of portfolio
6.27%
Previous 6.97%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Qvt Financial LP New York, NY65.8MShares$788 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$648 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$499 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$423 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.7MShares$355 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.43B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...